Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Toxiphage Forte
- Development stage
- Unknown
- Lead developer
- Biokindle Lifesciences
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Toxiphage Forte is an oral prebiotic and probiotic formulation developed by Biokindle Lifesciences to reduce the accumulation of uremic toxins in patients with chronic kidney disease (CKD). The formulation contains 90 billion CFU of three probiotic strains—Bifidobacterium longum, Lactobacillus acidophilus, and Streptococcus thermophilus—along with the prebiotic fructooligosaccharides (FOS). These probiotics utilize and metabolize nitrogenous waste products such as urea, creatinine, uric acid, p-cresyl sulfate, and indoxyl sulfate as nutrients, thereby facilitating their clearance from the bloodstream via the intestinal tract and slowing the progression of CKD. Toxiphage Forte is also used to support overall gut health, manage digestive disorders like diarrhea and irritable bowel syndrome (IBS), and boost immune function.
- Brand names
- Toxiphage Forte
- Other names
- Toxiphage Forte 90 Billion CFU
02
Targets
IS (Indoxyl sulfate)
Beyond the preview
Go deeper on Toxiphage Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Toxiphage Forte.